NEOG
NASDAQNeogen Corporation
News · 26 weeks34+175%
2026-03-012026-08-23
Mix1890d
- Insider9(50%)
- SEC Filings6(33%)
- Other1(6%)
- Earnings1(6%)
- Offering1(6%)
Latest news
25 items- SECSEC Form DEFA14A filed by Neogen CorporationDEFA14A - NEOGEN CORP (0000711377) (Filer)
- SECSEC Form DEF 14A filed by Neogen CorporationDEF 14A - NEOGEN CORP (0000711377) (Filer)
- INSIDERChief Accounting Officer Moylan John Patrick covered exercise/tax liability with 2,365 units of Restricted Stock Units, decreasing direct ownership by 7% to 29,331 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERCEO Nassif Mikheal covered exercise/tax liability with 20,397 units of Restricted Stock Units, decreasing direct ownership by 44% to 25,655 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERChief Accounting Officer Moylan John Patrick was granted 8,584 units of Restricted Stock Units, increasing direct ownership by 36% to 32,155 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERSenior Vice President Ranalli Tamara A. was granted 25,751 shares (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERChief Legal Officer Stacey Jennifer Evans was granted 38,627 shares (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERCFO Riggsbee Richard Bryan was granted 51,502 shares (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERCEO Nassif Mikheal was granted 141,631 shares (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- SECNeogen Corporation filed SEC Form 8-K: Leadership Update8-K - NEOGEN CORP (0000711377) (Filer)
- INSIDERCEO Nassif Mikheal bought $4,370 worth of shares (370 units at $11.81) (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- SECSEC Form 10-K filed by Neogen Corporation10-K - NEOGEN CORP (0000711377) (Filer)
- SECNeogen Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - NEOGEN CORP (0000711377) (Filer)
- PRNeogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial ResultsDelivered Strong Core Growth in Q4 FY26 with Food Safety Core Growth Highest Since FY23 Fiscal fourth quarter 2026 revenue of $225.3 million representing growth of (0.1%) and Core Growth1 of 4.3%; Full fiscal year 2026 revenue of $870.4 million with growth of (2.7%) and Core Growth1 of 1.9% Food Safety fourth quarter revenue growth of 3.1% and Core Growth1 of 5.8%; highest quarterly core growth rate since FY 2023 Animal Safety fourth quarter revenue growth of (8.2%), Core Growth1 of 0.5%; revenue grew 7% sequentially due to resolution of the majority of supply challenges Net loss of $11.3 million in the fourth quarter 2026 with EPS of $(0.05); Adjusted Net Income1 of $18.7 milli
- PRNeogen to Release Fourth-Quarter Fiscal Year 2026 Financial Results on July 30, 2026Neogen® Corporation (NASDAQ:NEOG) will issue its fourth-quarter earnings release before the opening of the market on Thursday, July 30, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time. During the call, Neogen management will provide a financial overview and business update of the company’s performance for the fourth-quarter of fiscal year 2026. The conference call can be accessed by dialing: Toll-Free - North America: 1-833-461-5787 International: (+1) 626-884-3620 Conference ID: 741 914 740 The live webcast can also be accessed through Neogen’s Investor Relations webpage, neogen.com/investor-relatio
- SECSEC Form 11-K filed by Neogen Corporation11-K - NEOGEN CORP (0000711377) (Filer)
- PRNeogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World ScrewwormCompany expands availability of FIFRA 2(ee) recommendations to counter threat Neogen Corporation (NASDAQ:NEOG), an innovative leader in food and animal safety solutions, today announced the expanded availability of FIFRA* Section 2(ee) recommendations for the use of Prozap® Insectrin X Concentrate and Prozap® Screw Worm and Ear Tick Aerosol as part of New World Screwworm (NWS) response efforts. These recommendations provide ranchers, livestock producers, and horse owners with an additional option to support fly management efforts. In Texas, the Texas Department of Agriculture has approved Section 2(ee) recommendations for these products. Neogen is also making Section 2(ee) recommendatio
- INSIDERChief Accounting Officer Moylan John Patrick covered exercise/tax liability with 2,553 units of Restricted Stock Units, decreasing direct ownership by 10% to 23,571 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- SECSEC Form SD filed by Neogen CorporationSD - NEOGEN CORP (0000711377) (Filer)
- INSIDERFormer Chief Legal Officer Rocklin Amy M exercised 35,183 shares at a strike of $9.29 and covered exercise/tax liability with 10,241 shares, increasing direct ownership by 44% to 82,182 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERChief Accounting Officer Moylan John Patrick exercised 4,558 shares at a strike of $9.53 and covered exercise/tax liability with 1,568 shares, increasing direct ownership by 21% to 17,337 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERChief Legal Officer Stacey Jennifer Evans was granted 39,349 shares (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- PRNeogen's Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ CertificationNeogen® Corporation (NASDAQ:NEOG), an innovative leader in food safety solutions, today announced that its Molecular Detection Assay - Listeria Right Now™ rapid environmental monitoring test has received AOAC® Performance Tested Methods℠ (PTM) certification (No. 042604), validating the test's performance for the enrichment-free detection of viable and non-viable Listeria species on stainless steel surfaces. The technology allows technicians to perform the assay without first enriching the sample by growing the bacteria in culture media. Combined with the ease-of-use and speed advantages associated with Neogen's Molecular Detection System ™, this makes Neogen's test one of the fastest molecu
- SECNeogen Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - NEOGEN CORP (0000711377) (Filer)
- INSIDERSEC Form 3 filed by new insider Stacey Jennifer Evans3 - NEOGEN CORP (0000711377) (Issuer)
NEOG FAQ
7 questionsWhat does Neogen Corporation do?
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid...Where does NEOG stock trade?
Neogen Corporation (NEOG) is listed on NASDAQ.What sector and industry is NEOG in?
Neogen Corporation operates in the Health Care sector, Biotechnology: In Vitro & In Vivo Diagnostic Substances industry.When did Neogen Corporation go public?
Neogen Corporation (NEOG) completed its IPO in 1989.What are analysts saying about NEOG?
Neogen Corporation has had 5 recent analyst actions on file. The most recent action was from William Blair: Mkt Perform on 2025-07-29. Recent price targets range from $1500.00 to $2500.00.What companies are similar to NEOG?
Notable peers in the same industry include IDXX (IDEXX Laboratories Inc.), ORKA (Oruka Therapeutics Inc.), LNTH (Lantheus Holdings Inc.), OCDX (Ortho Clinical Diagnostics Holdings plc), CLDX (Celldex Therapeutics Inc.). Compare NEOG side-by-side with any of them on Quantisnow.How can I track NEOG on Quantisnow?
Quantisnow aggregates Neogen Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NEOG to receive live email and push alerts on every new disclosure.